Sodium-glucose cotransporter 2 inhibitors for the management of heart failure

被引：0

作者：

Nouel, Ana ^{[1
,2
]}

Winter, Jose Luis ^{[1
,2
]}

Sepulveda, Luis ^{[1
]}

机构：

[1] Clin Alemana Santiago, Dept Enfermedades Cardiovasc, Santiago, Chile

[2] Complejo Asistencial Dr Sotero Rio, Serv Cardiol, Santiago, Chile

来源：

REVISTA MEDICA DE CHILE | 2022年 / 150卷 / 12期

关键词：

Clinical Trial; Heart Failure; Sodium-Glucose Transporter 2 Inhibitors; DIASTOLIC DYSFUNCTION; EMPAGLIFLOZIN; MECHANISMS; MORBIDITY; THERAPIES; MORTALITY; TRIAL;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure (HF) is a global health problem. There is a strong association h between HF and type 2 diabetes mellitus (DM2), with an increasing prevalence of patients having both conditions concomitantly. Sodium-glucose cotransporter 2 inhibitors (ISGLT2) significantly reduce cardiovascular events, including cardiovascular death. In this article we will focus on the current evidence about the effectiveness of these medications in adults with heart failure with reduced or preserved ejection fraction.

引用

页码：1647 / 1654

页数：8

共 38 条

[1] SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models [J].

Andreadou, Ioanna ;

Bell, Robert M. ;

Botker, Hans Erik ;

Zuurbier, Coert J. .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (07)

[2] Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Ferreira, Joao P. ;

Bocchi, Edimar ;

Boehm, Michael ;

Brunner-La Rocca, Hans-Peter ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure-Valenzuela, Eduardo ;

Giannetti, Nadia ;

Gomez-Mesa, Juan Esteban ;

Janssens, Stefan ;

Januzzi, James L. ;

Gonzalez-Juanatey, Jose R. ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio V. ;

Pina, Ileana L. ;

Ponikowski, Piotr ;

Senni, Michele ;

Sim, David ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Tsutsui, Hiroyuki ;

Verma, Subodh ;

Vinereanu, Dragos ;

Zhang, Jian ;

Carson, Peter ;

Lam, Carolyn Su Ping ;

Marx, Nikolaus ;

Zeller, Cordula ;

Sattar, Naveed ;

Jamal, Waheed ;

Schnaidt, Sven ;

Schnee, Janet M. ;

Brueckmann, Martina ;

Pocock, Stuart J. ;

Zannad, Faiez ;

Packer, Milton .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461

[3] Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure [J].

Bhatt, Deepak L. ;

Szarek, Michael ;

Steg, P. Gabriel ;

Cannon, Christopher P. ;

Leiter, Lawrence A. ;

McGuire, Darren K. ;

Lewis, Julia B. ;

Riddle, Matthew C. ;

Voors, Adriaan A. ;

Metra, Marco ;

Lund, Lars H. ;

Komajda, Michel ;

Testani, Jeffrey M. ;

Wilcox, Christopher S. ;

Ponikowski, Piotr ;

Lopes, Renato D. ;

Verma, Subodh ;

Lapuerta, Pablo ;

Pitt, Bertram .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :117-128

[4] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease [J].

Bhatt, Deepak L. ;

Szarek, Michael ;

Pitt, Bertram ;

Cannon, Christopher P. ;

Leiter, Lawrence A. ;

McGuire, Darren K. ;

Lewis, Julia B. ;

Riddle, Matthew C. ;

Inzucchi, Silvio E. ;

Kosiborod, Mikhail N. ;

Cherney, David Z. I. ;

Dwyer, Jamie P. ;

Scirica, Benjamin M. ;

Bailey, Clifford J. ;

Diaz, Rafael ;

Ray, Kausik K. ;

Udell, Jacob A. ;

Lopes, Renato D. ;

Lapuerta, Pablo ;

Steg, P. Gabriel .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :129-139

[5] Drug therapies in chronic heart failure: a focus on reduced ejection fraction [J].

Bolam, Helena ;

Morton, Geraint ;

Kalra, Paul R. .

CLINICAL MEDICINE, 2018, 18 (02) :138-145

[6] The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis [J].

Bouthoorn, Selma ;

Valstar, Gideon B. ;

Gohar, Aisha ;

den Ruijter, Hester M. ;

Reitsma, Hans B. ;

Hoes, Arno W. ;

Rutten, Frans H. .

DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (06) :477-493

[7]

Buckley Leo F, 2019, F1000Res, V8, DOI 10.12688/f1000research.20447.1

[8] The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors [J].

Butler, Javed ;

Hamo, Carine E. ;

Filippatos, Gerasimos ;

Pocock, Stuart J. ;

Bernstein, Richard A. ;

Brueckmann, Martina ;

Cheung, Alfred K. ;

George, Jyothis T. ;

Green, Jennifer B. ;

Januzzi, James L. ;

Kaul, Sanjay ;

Lam, Carolyn S. P. ;

Lip, Gregory Y. H. ;

Marx, Nikolaus ;

McCullough, Peter A. ;

Mehta, Cyrus R. ;

Ponikowski, Piotr ;

Rosenstock, Julio ;

Sattar, Naveed ;

Salsali, Afshin ;

Scirica, Benjamin M. ;

Shah, Sanjiv J. ;

Tsutsui, Hiroyuki ;

Verma, Subodh ;

Wanner, Christoph ;

Woerle, Hans-Juergan ;

Zannad, Faiez ;

Anker, Stefan D. .

EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) :1390-1400

[9]

Cohen ND, 2019, INTERN MED J, DOI [10.1111/imj.1426, DOI 10.1111/IMJ.1426]

[10] Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry [J].

de Frutos, Fernando ;

Mirabet, Sonia ;

Ortega-Paz, Luis ;

Buera, Irene ;

Darnes, Sara ;

Farre, Nuria ;

Andres, Bernardo ;

Adelino, Raquel ;

Bascompte, Ramon ;

Perez-Rodon, Jordi ;

Aparicio, Xavier ;

Sutil-Vega, Mario ;

Soto, Adriana ;

Faraudo, Mercedes ;

Cainzos-Achirica, Miguel ;

Manito, Nicolas .

ESC HEART FAILURE, 2020, 7 (01) :26-36

← 1 2 3 4 →